21268 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
TETRODOTOXIN LIQUID FORMULATIONS
#302Therapeutic uses for sodium thiosulfate formulations
#303TOPICAL TREATMENT OF HERPES INFECTIONS
#304PHARMACEUTICAL COMPOSITIONS OF MOSUNETUZUMAB AND METHODS OF USE
#305STABILIZED LIQUID COMPOSITIONS COMPRISING A LEVODOPA-TYROSINE CONJUGATE AND USES THEREOF
#306Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#307METHODS FOR PRODUCING STABLE THERAPEUTIC FORMULATIONS IN APROTIC POLAR SOLVENTS
#308BORONIC ACID COMPOUNDS, COMPOSITIONS AND METHODS
#309PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB FOR ORAL ADMINISTRATION
#310Hydrocortisone acetate suppository formulation for treatment of disease
#311Hydrocortisone acetate suppository formulation for treatment of disease
#312Hydrocortisone acetate suppository formulation for treatment of disease
#313Pharmaceutical Composition
#314METHOD FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN SPECIFIC PATIENTS USING MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS
#315KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS
#316Hydrocortisone acetate suppository formulation for treatment of disease
#317Hydrocortisone acetate suppository formulation for treatment of disease
#318Method for Assessing Atenolol with Precision
#319Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine
#320Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis
#321Liquid Protein Formulations Containing Viscosity-Lowering Agents
#322SOLUTION FORMULATION OF CYCLOPHOSPHAMIDE
#323EXOSOME SYSTEMS, PRODUCTS AND METHODS
#324Opthalmic Compositions for Dry Eye Treatment and Methods of Manufacture of the Same
#325THERAPEUTIC PHARMACEUTICAL COMPOSITIONS
#326TOPICAL COMPOSITIONS CONTAINING ANTHRANILIC ACID DERIVATIVES AND METHODS FOR TREATING SKIN DISORDERS
#327Anhydrous Sodium Thiosulfate and Formulations Thereof
#328ANTI-GAL3 ANTIBODY FORMULATIONS AND METHODS OF USE THEREOF
#329STABLE FORMULATIONS OF INDOCYANINE GREEN
#330Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
#331NOVEL APPLICATIONS OF HYALURONIC ACID FOR TREATMENT OF PAIN AND PRURITIS
#332ORALLY ADMINISTRABLE FORMULATION
#333Topical NSAID Formulation with Improved Skin Absorption
#334METHODS AND COMPOSITIONS FOR THE TREATMENT OF DRUG RESISTANT TOPICAL INFECTIONS
#335Pharmaceutical composition and administrations thereof
#336Drug delivery formulations
#337Liquid Pharmaceutical Composition Comprising an Anti-IL-6 Receptor Antibody
#338COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY MITOCHONDRIAL DYSFUNCTION, CONTAINING ISOQUINOLINE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT
#339Composition for Treatment and/or Prevention of a Corona Virus Infection
#340STABLE LEVOTHYROXINE COMPOSITIONS IN APROTIC POLAR SOLVENTS
#341SUSTAINED RELEASE INJECTABLE THERAPEUTIC FORMULATIONS USING APROTIC POLAR SOLVENTS
#342TOPICAL COMPOSITIONS AND METHODS FOR TREATMENT
#343THERAPEUTICALLY ACTIVE ALDESLEUKIN HIGHLY STABLE IN LIQUID PHARMACEUTICAL COMPOSITIONS
#344TOPICAL FORMULATIONS OF A JAK 1/3 INHIBITOR AND METHODS OF USE THEREOF FOR TREATMENT OF ATOPIC DERMATITIS AND OTHER SKIN CONDITIONS
#345TOPICAL NAPROXEN FORMULATIONS AND THEIR USE
#346TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#347AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL
#348PHARMACEUTICAL COMPOSITIONS COMPRISING RANPIRNASE
#349ELECTRORESPONSIVE BIOPOLYMER CAPSULES FOR ELECTRICALLY MEDIATED DELIVERY OF ACTIVES
#350LIPOCATIONIC DENDRIMERS AND USES THEREOF
#351LIPOCATIONIC DENDRIMERS AND USES THEREOF
#352METHODS AND COMPOSITIONS COMPRISING AN ANTI-CTLA4 MONOCLONAL ANTIBODY WITH REDUCED HOST CELL PROTEINS AND INCREASED POLYSORBATE-80 STABILITY
#353COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES
#354Coronavirus vaccine compositions and methods
#355METHISOPRINOL COMPOSITIONS
#356Composition for Treating Hair and Scalp
#357EUTECTIC MATRIX FOR NUTRACEUTICAL COMPOSITIONS
#358Botanical formulations
#359TRANSDERMAL COMPOSITIONS OF IBUPROFEN AND METHODS OF USE THEREOF
#360FORMULATIONS
#361METHOD FOR SELECTING, ASSESSING, OR PRODUCING SODIUM LAURYL SULFATE AS RAW MATERIAL FOR PHARMACEUTICAL FORMULATION, OR FORMULATION OR THE LIKE CONTAINING SAME
#362HYDROGEL COMPOSITION AND USES THEREOF IN THE PREVENTION AND/OR TREATMENT OF SKIN DAMAGE CAUSED BY RADIATION
#363Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
#364COMPOSITIONS AND METHODS FOR STORAGE STABLE OPHTHALMIC DRUGS
#365EPINEPHRINE FORMULATIONS
#366LIPOCATIONIC DENDRIMERS AND USES THEREOF
#367EXPEC GLYCOCONJUGATE VACCINE FORMULATIONS
#368FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS
#369FULVESTRANT FORMULATIONS
#370Compositions and methods for treating pain with wogonin
#371TOPICAL COMPOSITIONS AND METHODS OF PREPARING THE SAME
#372FORMULATIONS OF BENDAMUSTINE
#373FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#374Trace element compositions, methods of making and use
#375ORAL HYALURONIC ACID COMPOSITION
#376Treatment of diabetic retinopathy
#377OCULAR INFLAMMATION TREATMENT WITH STABILIZED DEXAMETHASONE
#378Treatment of ocular inflammation
#379Stabilized dexamethasone compositions
#380PH STABILIZED TOPICAL OPHTHLAMIC COMPOSITIONS
#381PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF AND CONTAINING SULFUR-BASED ANTIOXIDANT
#382Epinephrine formulations
#383Topical Composition of Pirfenidone
#384STABLE ANTIBODY FORMULATION, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF
#385BOTANICAL FORMULATIONS
#386IMMUNO-POTENTIATING ENZYMATIC EXTRACT OF DEER ANTLER THAT EXCELLENTLY ENHANCES ACTIVITY OF IMMUNE CELL INCLUDING NK CELL
#387TRIPLE STABILIZER SYSTEM
#388PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIES
#389Lipocationic dendrimers and uses thereof
#390Lipids and compositions for the delivery of therapeutics
#391ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF
#392METHODS FOR PRODUCING STABLE THERAPEUTIC FORMULATIONS IN APROTIC POLAR SOLVENTS
#393Preparation of preliposomal annamycin lyophilizate
#394PHARMACEUTICAL COMPOSITION
#395COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS
#396ORAL LIQUID SUSPENSION OF PAN-RAF KINASE INHIBITOR
#397LIPOCATIONIC DENDRIMERS AND USES THEREOF
#398PHARMACEUTICAL COMBINATION OF A CORTICOSTEROID AND AN ANTIHISTAMINE FOR THE TREATMENT AND CONTROL OF THE INFLAMMATORY COMPONENT OF ALLERGIC PROCESSES
#399ATALUREN EYE DROP FORMULATION
#400Materials and methods for improving gastrointestinal function
#401FORMULATIONS FOR HEALING OF TRAUMATIC LESIONS OF THE SKIN AND MUCOUS MEMBRANES
#402MULTIVALENT TERPENE-BASED BOLAAMPHIPHILES FOR GENE DELIVERY
#403Multi-functional hemocompatible porous bead sorbent for removing protein based toxins and potassium from biological fluids
#404CLEAVABLE CONJUGATES OF CATECHOL COMPOUNDS AND WATER-SOLUBLE POLYMERS AND METHODS OF TREATMENT USING THE SAME
#405Pharmaceutical Composition Comprising Mineralocorticoid Receptor Antagonist and Use Thereof
#406IONIC LIQUIDS FOR DRUG DELIVERY
#407Lipocationic dendrimers and uses thereof
#408COMPOUND EXTERNAL PREPARATION FOR TREATING ALOPECIA AREATA AND PREPARATION METHOD THEREFOR
#409Antibody Compositions and Methods of Use Thereof
#410Small Molecule Compounds and Compositions
#411Compositions and methods for storage stable ophthalmic drugs
#412HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#413COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
#414PEPTIDE FORMULATIONS AND METHODS OF USE
#415PHARMACEUTICAL COMPOSITIONS OF THERAPEUTIC PROTEINS AND METHODS OF USE
#416THERAPEUTIC OR EXERCISE ELASTOMER PUTTY SPECIALLY FORMULATED WITH CBD OIL AND/OR DMSO TO REDUCE PAIN AND INFLAMMATION DURING HAND EXERCISE OR REHABILITATION
#417Bortezomib compositions
#418IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE
#419PSEUDO-TERNARY PHASE SYSTEM FOR IMPROVING SOLUBILITY OF A PHARMACEUTICALLY ACTIVE INGREDIENT
#420USE OF B-CELL LYMPHOMA 2 (BCL-2) INHIBITOR AND PHARMACEUTICAL COMPOSITION FOR TREATING CELLULAR SENESCENCE-RELATED SKIN DISEASES
#421Pharmaceutical compositions of tofacitinib for oral administration
#422COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#423METHODS AND COMPOSITIONS USEFUL FOR REDUCING BIOBURDEN IN WOUNDS
#424Niclosamide formulations and methods of use
#425NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#426VISCOSITY-REDUCING EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#427Stable liquid compositions of glucagon
#428RINSE-OFF COMPOSITIONS AND USES THEREOF FOR DELIVERY OF ACTIVE AGENTS
#429AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS
#430CHOLESTANE DERIVATIVES, PREPARATIONS CONTAINING THESE DERIVATIVES AND USE THEREOF
#431PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
#432Epinephrine spray formulations
#433PHARMACEUTICAL FORMULATIONS OF FCRN INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION
#434PHOTODYNAMIC THERAPY COMPOSITIONS AND METHODS OF USE THEREOF
#435Pharmaceutical Formulations
#436HYDROXYAPATITE COMPOSITION FOR TREATMENT AND/OR PREVENTION OF A VIRUS INFECTION
#437FORMULATIONS OF ANTI-VIRAL COMPOUNDS
#438Compositions and methods for treating epilepsy, seizures and other conditions
#439PHARMACEUTICAL FORMULATION
#440Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
#441Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
#442TREATMENT OF SKIN DISORDERS WITH TOPICAL TAPINAROF COMPOSITIONS
#443HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION
#444Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#445Laureth-4 containing topical formulations
#446Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
#447Pharmaceutical compositions of mosunetuzumab and methods of use
#448METHOD TO PREPARE THERAPEUTICALLY ACTIVE ALDESLEUKIN HIGHLY STABLE IN LIQUID PHARMACEUTICAL COMPOSITIONS
#449METHODS FOR TREATING CONGENITAL EPIDERMAL HYPERPLASIA AND COMPOSITIONS FOR SAME
#450USE OF MITOXANTRONE PREPARATION IN PREPARATION OF DRUG FOR DIAGNOSING AND TREATING BREAST CANCER
#451SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS
#452COMPOSITIONS AND METHODS FOR LOWERING INTRACRANIAL PRESSURE
#453COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF
#454High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
#455INJECTABLE DEPOT COMPOSITIONS FOR THE DELIVERY OF ANTIVIRAL AGENTS
#456METHODS OF TREATING NEW-ONSET PLAQUE TYPE PSORIASIS USING IL-17 ANTAGONISTS
#457Trace element compositions, methods of making and use
#458Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol
#459Penetrating topical pain relief compositions and methods of use
#460OXINE-CONTAINING CELL RADIOLABELLING AGENTS
#461Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#462USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#463Production of biosimilar ustekinumab in CHO cells
#464LIQUID FORMULATION OF LONG-ACTING CONJUGATE OF GLUCAGON, GLP-1, AND GIP TRIGONAL AGONIST
#465FORMULATIONS OF BENDAMUSTINE
#466Stable pharmaceutical compositions of apixaban
#467VISCOSITY REDUCING EXCIPIENTS AND COMBINATIONS THEREOF FOR HIGHLY CONCENTRATED PROTEIN FORMULATIONS
#468COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#469Compositions and Methods for Treating, Ameliorating and/or Preventing Cancer and Kits for the Same
#470FIBROBLAST GROWTH FACTOR 7 PEPTIDE
#471EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#472THERMO-SENSITIVE PERMEATION ENHANCING FORMULATIONS FOR DRUG DELIVERY
#473Non-lethal defensive fluid composition and pressurized delivery system
#474TREATMENT OF INTERVERTEBRAL DISC DEGENERATION AND DISCOGENIC BACK PAIN
#475Cannabinoid Monoterpene Based Pharmaceutical Topical Composition For MusculoSkeletal Pain
#476USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#477Long Acting Injectable Formulations
#478TRANSDERMAL COMPOSITIONS OF IBUPROFEN AND METHODS OF USE THEREOF
#479FORMULATIONS OF BENDAMUSTINE
#480RAPAMYCIN (RAPA) SELF-MICROEMULSIFYING INJECTION AND PREPARATION METHOD AND USE THEREOF
#481CURCUMIN COMPOSITIONS FOR OSTEOARTHRITIS AND JOINT WELLNESS
#482DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
#483Compositions and methods for treating epilepsy, seizures and other conditions
#484Topical formulations of cyclooxygenase inhibitors and their use
#485LIQUID PHARMACEUTICAL COMPOSITION
#486Methods for aneurysm treatment
#487Compositions and methods for deep dermal drug delivery
#488METHODS AND COMPOSITIONS FOR TREATMENT OF SOLID TUMORS
#489NOVEL TRANSDUCTION ENHANCERS AND USES THEREOF
#490BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT
#491Bortezomib compositions
#492PHARMACEUTICAL AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA
#493Compounded compositions and methods for treating pain
#494TREATMENT OF SCHIZOPHRENIA USING BETA-CARYOPHYLLENE AND CB2 RECEPTOR AGONISTS
#495Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents
#496LIQUID FORMULATION
#497ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF
#498ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF
#499ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF
#500Pneumococcal conjugate vaccine formulations
#501METAL COMPOSITIONS AND METHODS OF USE THEREOF
#502PERCUTANEOUS ABSORPTION PREPARATION COMPRISING DONEPEZIL WITH IMPROVED STABILITY
#503Methods and compositions for treating cancer
#504MEK INHIBITORS FOR CORNEAL SCARRING AND NEOVASCULARIZATION
#505PHARMACEUTICAL COMPOSITION
#506ANTIBODY AND PROTEIN FORMULATIONS
#507Stable formulations of SHR0302
#508Aqueous formulation comprising paracetamol and ibuprofen
#509METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE I
#510PHARMACEUTICAL FORMULATION
#511High concentration antibody-containing liquid formulation
#512BOTULINUM TOXIN PRE-FILLED INJECTABLE FORMULATION THAT FACILITATES DISCHARGE RATE CONTROL AND IS STABLE
#513LIQUID FORMULATION AND PHARMACEUTICAL PRODUCT CONTAINING CILASTATIN
#514HSP70 Inhibitors and Methods of Using Same
#515Therapeutic uses for sodium thiosulfate formulations
#516CLOSTRIDIAL TOXIN - HYALURONIC ACID COMPOSITIONS
#517AGENT FOR INCREASING CD25-POSITIVE REGULATORY T CELLS IN KIDNEYS
#518HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#519METHOD FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL COMPOSITION COMPRISING A HIGH PENETRATION DRUG, AND THE PHARMACEUTICAL COMPOSITION OBTAINED THEREFROM
#520TREATMENT
#521PHARMACEUTICAL COMPOSITIONS OF SPIRONOLACTONE FOR DEEP DERMAL DRUG DELIVERY
#522Pharmaceutical Preparations Of Melatonin Suitable For Intranasal Administration
#523COMPOSITIONS AND METHODS FOR INHIBITING VIBRIO INFECTION
#524COMPOSITIONS FOR PREVENTING OR TREATING VIRAL AND OTHER MICROBIAL INFECTIONS
#525CELL PRESERVATION METHOD
#526STABILIZER FOR RADIOPHARMACEUTICALS AND RADIOPHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#527NON-RINSED VETERINARY COMPOSITIONS
#528Antiseptic compositions
#529PHARMACEUTICAL COMPOSITION
#530DIAGNOSTIC METHODS USING PCG-1A EXPRESSION
#531COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION
#532RETINAL PIGMENT EPITHELIUM CELL COMPOSITIONS
#533DIAGNOSTIC METHODS USING SIRT1 EXPRESSION
#534MICROMOLECULE PI4KIIIalpha INHIBITOR COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF
#535Formulations of Bendamustine
#536Formulations of bendamustine
#537PENICILLIN-BINDING PROTEIN INHIBITORS
#538NOVEL COMPOSITIONS FOR TREATMENT OF CORONAVIRUS DISEASE
#539ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#540PREPARATION CONTAINING TETRACYCLIC COMPOUND AT HIGH DOSE
#54111-(4-CHLOROPHENYL)-4-(2,3-DIHYDRO-1H-INDOLE-1-CARBONYL)-3,11-DIMETHYL-5,10,DIOXATRICYCLO[7.4.0.0,2,6,]TRIDECA-1,3,6,8-TETRAEN-13-ONE AND DERIVATIVES AS DESTABILIZER OF CRY1 FOR THE TREATMENT OF CIRCADIAN RHYTHM ASSOCIATED DISEASES AND DISORDERS
#542MICELLES AND VESICLES FOR THE DELIVERY OF GLYCOPEPTIDES
#543Bortezomib compositions
#544Topical formulations containing mTOR inhibitors
#545EPINEPHRINE FORMULATIONS
#546NANOMETRIC PHARMACEUTICAL COMPOSITION IN THE FORM OF LIPOSOMES OR NANOEMULSION CONTAINING SPECIFIC SEQUENCES OF INTERFERENCE RNA
#547Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol
#548BORTEZOMIB COMPOSITIONS
#549METHOD FOR TREATING CHRONIC GRAFT VERSUS HOST DISEASE
#550DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
#551Therapeutic uses for sodium thiosulfate and formulations
#552Therapeutic uses for sodium thiosulfate formulations
#553Subcutaneous HER2 antibody formulations
#554SUBSTANCE DELIVERY CARRIER AND COMPOSITION
#555BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#556INHALABLE LIPOSOMAL SUSTAINED RELEASE COMPOSITION FOR USE IN TREATING PULMONARY DISEASES
#557Composition for ameliorating psoriasis comprising cimicifugolide a as active ingredient
#558Sulfate-free cleansing composition that confers high salicylic acid deposition
#559COMPOSITIONS INCLUDING AMELOGENIN AND USES THEREOF
#560DICLOFENAC SODIUM CONTAINING PATCH
#561METHODS OF SEPARATING HOST CELL LIPASES FROM AN ANTI-LAG3 ANTIBODY PRODUCTION
#562Combination therapy for cancer treatment
#563DICLOFENAC SODIUM CONTAINING PATCH
#564PHARMACEUTICAL COMPOSITION OF CYCLOOXYGENASE - 2 INHIBITORS
#565STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS
#566IMMUNOGENIC COMPOSITION
#567EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING
#568Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#569LIPOSOMAL FORMULATIONS OF BCL INHIBITORS
#570Photodynamic therapy compositions and methods of use thereof
#571Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for Same
#572PHARMACEUTICAL FORMULATIONS OF TNF-ALPHA ANTIBODIES
#573Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
#574STABLE FORMULATIONS COMPRISING THIOTEPA
#575ANTI-PD-L1 ANTIBODY FORMULATIONS
#576ANTI-TGF-BETA ANTIBODY FORMULATIONS AND THEIR USE
#577Method of Treating Acute Exacerbation of Schizophrenia with Long-Acting Injectable Depot Composition
#578Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition
#579Viscosity-reducing excipient compounds for protein formulations
#580Pharmaceutical composition comprising a GLP-1-agonist and methionine
#581EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS
#582Stable formulations comprising thiotepa
#583Injectable drug delivery implant composition and method of use thereof
#584EXOSOME SYSTEMS, PRODUCTS AND METHODS
#585IODINE AND POLYOL COMPOSITION, METHOD, AND USE
#586Oxygen gas sustained released nano-emulsion composition and method for producing the same
#587Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one
#588Pharmaceutical Compositions, Formulations And Methods For The Treatment Of Retinoblastoma
#589MICRONEEDLE DEVICE
#590RETINAL PIGMENT EPITHELIUM CELL COMPOSITIONS
#591EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#592AGENT FOR USE IN TREATMENT OR PREVENTION OF OPHTHALMIC DISORDERS
#593COMPOSITIONS AND METHODS FOR TREATING EPILEPSY, SEIZURES AND OTHER CONDITIONS
#594Compositions and methods for treating epilepsy, seizures and other conditions
#595High Concentration Bispecific Antibody Formulations
#596Transdermal Drug Delivery Systems for Administration of a Therapeutically Effective Amount of Lenalidomide and Other Immunomodulatory Agents
#597ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#598Compositions of a polyorthoester and an aprotic solvent
#599PREPARATION OF A THERAPEUTIC COMPOSITION FOR TREATING AUTOIMMUNE DISEASES
#600FULVESTRANT FORMULATIONS